• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.58% Nasdaq Up 0.26%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    6.52 Down 0.03(0.46%) 4:00PM EDT
    |After Hours : 6.52 0.00 (0.00%) 4:42PM EDT
    Prev Close:6.55
    Open:6.52
    Bid:5.50 x 500
    Ask:6.81 x 1000
    1y Target Est:9.00
    Beta:2.58032
    Earnings Date:Nov 7 - Nov 11 (Est.)
    Day's Range:6.48 - 6.66
    52wk Range:3.61 - 8.37
    Volume:848,567
    Avg Vol (3m):1,592,730
    Market Cap:456.30M
    P/E (ttm):N/A
    EPS (ttm):-0.51
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PGNX

    Comparison

    Symbol% ChgMkt Cap
    PGNXDown 0.46%456.30M
    NKTRDown 0.63%2.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):26.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :0.13
    Quarterly EPS Est (Sep-16) :0.55
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):0.17

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include Azedra, a radiotherapeutic product candidate, which is in Phase IIb clin... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback